The Vasopressin V2 Receptor Antagonists: The Vaptans

Global Journal of Endocrinological Metabolism
doi 10.31031/gjem.2018.02.000529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Crimson Publishers

Related search

A Serine Cluster Prevents Recycling of the V2 Vasopressin Receptor

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1998English

Membrane Targeting and Determination of Transmembrane Topology of the Human Vasopressin V2 Receptor

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1996English

Role of Vasopressin Antagonists

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2008English

Generation and Phenotype of Mice Harboring a Nonsense Mutation in the V2 Vasopressin Receptor Gene

Journal of Clinical Investigation
Medicine
2000English

Azetidinones as Vasopressin V1a Antagonists

Bioorganic and Medicinal Chemistry
Organic ChemistryMolecular MedicineMolecular BiologyBiochemistryClinical BiochemistryPharmaceutical ScienceDrug Discovery
2007English

Evaluation and Management of Hyponatremia: An Emerging Role for Vasopressin Receptor Antagonists

Nature Clinical Practice Nephrology
2007English

Pharmacological Profile of VP-343, a Novel Selective Vasopressin V2 Receptor Antagonist, in Rats.

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2000English

V2 Receptor Antagonists in Cystic Kidney Diseases: An Exciting Step Towards a Practical Treatment

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2005English

V2 Vasopressin Receptor Mutation Y205c Causing Nephrogenic Diabetes Insipidus Retains Partial Function in Vitro. † 885

Pediatric Research
Child HealthPediatricsPerinatology
1996English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy